Balance Sheet for ImmunoGen Inc. (IMGN)

$ 4.845   -0.035 (-0.72%) Volume: 1.67m 3:15 PM EDT 6-Jul-2020
Statement: View:
Assets [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 06/2016
Cash and Equivalents 176,225 262,252 267,107 159,964 245,026
Restrictable Cash - - - - -
Marketable Securities - - - - -
Accounts Receivable 7,500 1,701 2,649 2,026 883
Loans Receivable - - - - -
Other Receivables 19,748 10,366 2,580 6,778 1,409
Receivables 27,248 12,067 5,229 8,804 2,292
Inventories, Raw Materials - - 40 357 317
Inventories, Work in Progress - - 998 1,835 590
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - - - - -
Inventories, Other - - 1,038 2,192 907
Inventories, Adjustments & Allowances - - - - -
Inventories - - 1,038 2,192 907
Prepaid Expenses 5,425 4,462 2,967 5,386 4,881
Current Deferred Income Taxes - - - - -
Other Current Assets - - - - -
Total Current Assets 208,898 278,781 276,341 176,346 253,106
Land and Improvements - - - - -
Buildings and Improvement 20,776 20,684 36,460 36,584 34,743
Machinery, Furniture and Equipment 18,683 31,598 35,106 35,635 36,237
Construction in Progress - 113 416 124 2,327
Fixed Assets, Other 15,587 - - - -
Fixed Assets, Total 55,046 52,395 71,982 72,343 73,307
Gross Fixed Assets 55,046 52,395 71,982 72,343 73,307
Accumulated Depreciation (32,466) (39,504) (57,444) (52,845) (50,603)
Net Fixed Assets 22,580 12,891 14,538 19,498 22,704
Intangibles - - - - -
Cost in Excess - - - - -
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets 3,784 3,709 3,797 3,020 3,430
Total Non-Current Assets 26,364 16,600 18,335 22,518 26,134
Total Assets 235,262 295,381 294,676 198,864 279,240
Liabilities [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 06/2016
Accounts Payable 9,933 11,365 8,562 7,895 11,510
Short Term Debt 2,971 - - - -
Notes Payable - - - - -
Accrued Expenses 13,618 19,814 15,193 10,474 9,073
Accrued Liabilities 13,618 19,814 15,193 10,474 9,073
Deferred Revenues 309 317 1,405 14,531 13,582
Current Deferred Income Taxes - - - - -
Other Current Liabilities 50,579 39,164 30,610 22,876 26,274
Total Current Liabilities 77,410 70,660 55,770 55,776 60,439
Long Term Debt 2,078 2,064 2,050 96,965 96,628
Deferred Income Tax 127,123 85,160 98,881 25,000 25,524
Other Non-Current Liabilities 210,097 211,685 254,751 198,973 204,477
Minority Interest - - - - -
Capital Lease Obligations 21,798 - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 233,973 213,749 256,801 295,938 301,105
Total Liabilities 311,383 284,409 312,571 351,714 361,544
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity (76,121) 10,972 (17,895) (152,850) (82,304)
Common Par 1,501 1,494 1,325 873 872
Additional Paid in Capital 1,209,846 1,192,813 1,009,362 778,847 770,511
Cumulative Translation Adjustments - - - - -
Retained Earnings (1,287,468) (1,183,335) (1,028,582) (932,570) (853,687)
Treasury Stock - - - - -
Other Equity Adjustments - - - - -
Total Capitalization (74,043) 13,036 (15,845) (55,885) 14,324
Total Equity (76,121) 10,972 (17,895) (152,850) (82,304)
Total Liabilities & Shareholder's Equity 235,262 295,381 294,676 198,864 279,240
Cash Flow (104,133) (168,843) (95,966) (156,733) (144,817)
Working Capital 131,488 208,121 220,571 120,570 192,667
Free Cash Flow (91,212) (171,668) 6,529 (85,062) (134,852)
Invested Capital (74,043) 13,036 (15,845) (55,885) 14,324
Shares Outstanding - Common Class Only 150,136 149,400 132,526 87,301 87,209
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 150,136 149,400 132,526 261,600 87,209
Total Common Shares Outstanding 150,136 149,400 132,526 87,301 87,209
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 148,311 139,946 98,068 87,102 86,976
Diluted Weighted Shares Outstanding 148,311 139,946 98,068 87,102 86,976